Navigation Links
Beckman Coulter Announces First Quarter 2008 Results
Date:4/30/2008

stockholders (10.5) (10.2)

Proceeds from issuance of stock 13.8 27.7

Repurchase of common stock held in

grantor trust (0.9) (0.7)

Excess tax benefits from share-based

payment transactions 2.3 8.8

Debt borrowings, net 28.4 (0.5)

Debt repayments (35.0) (6.0)

Debt acquisition costs - (0.3)

Net cash (used in) provided by

financing activities (1.9) 18.8

Effect of exchange rates on cash and cash

equivalents 3.5 0.5

Change in cash and cash equivalents (12.5) 14.1

Cash and cash equivalents-beginning of period 83.0 75.2

Cash and cash equivalents-end of period $70.5 $89.3

BECKMAN COULTER, INC.

REVENUE BY SEGMENT

(in millions)

(unaudited)

Three Months Ended

March 31, Constant

Reported Currency

2008 2007 Growth % Growth % *

Clinical Diagnostics

Chemistry and Clinical

Automation $215.6 $183.9 17.2% 12.9%

Cellular 231.5 194.4 19.1% 14.7%

Immunoassay and

Molecular Diagnostics 172.9 141.9 21.8% 17.4%

Total Clinical

Diagnostics 620.0 520.2 19.2% 14.8%

Life Sciences
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related biology technology :

1. Beckman Coulter Acquires Rights to Hepatitis C Virus
2. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
3. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
4. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
5. Beckman Coulter Releases the High-Volume UniCel(R) DxC 880i Integrated Work Cell
6. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
7. Beckman Coulter to Present at the JPMorgan Healthcare Conference
8. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
9. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
10. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Calif. , May 27, 2015  Two years ... biotech professionals, hackers and citizen scientists, Oakland ... $30,000 crowdfunding campaign promoting its mission to democratize science ... Temescal District. ... Based out of ...
(Date:5/27/2015)... May 27, 2015 ­ Caris Life Sciences®, ... of precision medicine, today announced it has appointed the ... center of excellence site in the Caris Centers of ... Levine Cancer Institute is one of the largest cancer ... 11,000 new cancer patients annually. Derek Raghavan , ...
(Date:5/26/2015)... CITY , Kalifornien und HILDEN, Deutschland, ... QIAGEN Clinical Insight ® ... von Genvarianten und die Erstellung dazugehöriger Berichte; ... ESHG     QIAGEN N.V. (NASDAQ: ... gab heute die Markteinführung von QIAGEN Clinical ...
(Date:5/26/2015)... May 26, 2015 Tianyin Pharmaceutical Inc. (NYSE ... in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... the Company,s Annual Meeting of Shareholders for fiscal year ... held at the Company,s office located in ... 9:00 AM (local time in Chengdu, China ...
Breaking Biology Technology:East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 2East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 2Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3
... June 19 /Xinhua-PRNewswire/ --,Shenzhen Beike Biotechnology Co., Ltd. ... providing safe and effective stem cell applications for,medical ... medical stem cell storage and processing facility in ... Storage Facility will be,one of the most highly ...
... Canopus,BioPharma, Inc. (OTC: CBIA), has confirmed the efficacy ... agent and has also demonstrated the,synergistic effect of ... (Erbitux) in two mice lung cancer models., ... "We at,Canopus are encouraged with the discovery of ...
... 19 Iomai,Corporation (Nasdaq: IOMI ) announced ... Alexander Von Gabain, Ph. D., the Chief Scientific,Officer ... at the Biotechnology,Industry Organization,s International Convention at a ... session will begin at 4 p.m. in room ...
Cached Biology Technology:Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 2Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 3Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 4CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux). 2Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today 2
(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/20/2015)... May 20, 2015 ... has announced the addition of the  ... Iris Recognition Market"  report to their ... research service analyses trends in the ... and commercial sectors, globally. Despite hardware ...
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... 2009It has long been suggested that healthy folate (the ... goes hand in hand with healthy nervous system development ... issue of the Journal of Child Psychology and ... linked to the development of attention-deficit/hyperactivity problems in children ...
... Technologies, a start-up company established by University of Delaware ... commercialize a high-precision detector -- a planar array infrared ... in solids, liquids, and gases, in quantities as small ... The revolutionary technology holds promise in multiple applications, ...
... wheat and barley lines resistant to Crown Rot a ... in lost yield every year. Crown Rot, which is ... by the fungus Fusarium . Dr Chunji Liu ... sophisticated screening methods to scan over 2400 wheat lines and ...
Cached Biology News:UD start-up company prepares to commercialize novel detector for medical, military applications 2UD start-up company prepares to commercialize novel detector for medical, military applications 3UD start-up company prepares to commercialize novel detector for medical, military applications 4
Detect and measure levels of mouse IgG2b antibody isotypes quickly and easily....
... Versatile state of the Art ... flask to dual 38,000 L fermentation. ... scale to production. Aseptic operation ... Batch, Fed-Batch, and Continuous Modes. ...
Request Info...
Immunogen: VDAC3 Protein Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: